Viewing Study NCT06006650


Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2026-01-22 @ 2:05 PM
Study NCT ID: NCT06006650
Status: RECRUITING
Last Update Posted: 2023-08-23
First Post: 2023-08-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell
Sponsor: Tang-Du Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoadjuvent View
None PD-1 Inhibitor View
None Chemotherapy View
None Esophageal Squamous Cell Carcinoma View
Keywords: